This review aims to examine several aspects, including innate immune dysregulation, angiotensin converting enzyme 2 (ACE2) expression, smoking, precocious differentiation of T lymphocytes, and immunosenescence in COPD patients, which may contribute to poor outcomes after infection with SARS-CoV-2. The gene discussed is ACE2; the disease is chronic obstructive pulmonary disease.